Singapore, Feb. 10 -- China-based Innovent Biologics, Inc. has announced a strategic collaboration with Eli Lilly and Company, in the US, to advance novel medicines in oncology and immunology. This ag... Read More
Singapore, Feb. 10 -- Saisei Ventures, a pioneering investment firm focused on advancing Japanese biotechnology and therapeutic innovations globally, announced the launch of Bridge-to-Biotech, a new i... Read More
Singapore, Feb. 9 -- South Korea-based startup Neurophet, an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, has announced that its software solution, Neurop... Read More
Singapore, Feb. 9 -- A study was recently conducted to support evidence-based decision making in Thailand and to help policymakers in low and middle income countries evaluate screening options for det... Read More
Singapore, Feb. 6 -- A new three phase project to enhance how patients are treated for chronic respiratory conditions in primary care will go ahead thanks to a $2 millionMedical Research Future Fund g... Read More
Singapore, Feb. 6 -- South Korea-based startup Sky Labs Inc. has entered intoan exclusive distribution agreement with Otsuka Pharmaceutical Co. for thering-type blood pressure monitor, 'CART BP pro', ... Read More
Singapore, Feb. 6 -- A pioneering fictional pandemic simulation exercise will be held in the Republic of Korea by the Korean Government, the Coalition for Epidemic Preparedness Innovations (CEPI) and ... Read More
Singapore, Feb. 6 -- Precision for Medicine, a global leader in biomarker-driven clinical research and development, has announced the opening of a new office in Singapore. This strategic expansion str... Read More
Singapore, Feb. 6 -- Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod(R) brand of products, has announced that its transformative Omnipod 5 Automated Insulin... Read More
Singapore, Feb. 5 -- A world-first clinical trial will test cancer vaccines designed specifically for children with advanced or treatment-resistant brain tumours, following a $2.578 million investment... Read More